Cohen Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Cohen Investment Advisors's BMY Position: Q1 2026 in Review
Cohen Investment Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.67% in Q1 2026, buying an estimated $3.67K and bringing the position to 9,512 shares worth $577K. The position accounts for 0.27% of the portfolio, ranked #57.
Cohen Investment Advisors first reported a position in BMY in Q4 2020 and has held it in 22 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Cohen Investment Advisors held 9,512 shares of Bristol-Myers Squibb worth $577K as of Q1 2026.
- Cohen Investment Advisors bought 63 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.67K.
- Bristol-Myers Squibb made up 0.27% of Cohen Investment Advisors's portfolio in Q1 2026, its #57 holding.
- Cohen Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 22 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Cohen Investment Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.